In this week’s issue:
- Epilepsy Therapy Project/Epilepsy Foundation: New Therapy – Commercialization Grants Program
- W. Garfield Weston Foundation – Transformational Request for Proposals on Neurodegenerative Diseases of Aging
- Canada Research Chairs Internal Faculty of Medicine Competition (reminder)
- 4 What Matters Foundation UBC Diabetes Fellowship
- Scottish Rite Charitable Foundation – Research Grants
Awards and Honours:
- Keio University Medical Science Fund – Keio Medical Science Prize
- The Michael Smith Foundation for Health – Aubrey J. Tingle Prize and Lecture
- The Michael Smith Foundation for Health – Aubrey J. Tingle Prize and Lecture
- The Centre for Blood Research Seminar Series (1 attachment)
- SPARC – NSERC Collaborative Research and Development (CRD) Grant Workshop
- CIHR/NSERC Collaborative Health Research Projects (CHRP) Program
LOI Deadline: February 28, 2013
The New Therapy – Commercialization Grants Program is a unique partnership between two leading epilepsy non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation. The mission of the New Therapy – Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source.
LOI Deadline: March 25, 2013 (by 8:00am PST)
The W. Garfield Weston Foundation is seeking proposals for high potential, translational research or clinical trials that will have transformational impact in neurodegenerative diseases of aging.
To be eligible, projects must fall into one of these two categories to be considered:
– Preclinical to Phase III development of a therapeutic
– Development of tools that help accelerate the development of therapeutics e.g., animal models, imaging techniques or reagents, biomarkers or diagnostics
The Foundation defines translational and therapeutic as follows:
– Translational: Applied research towards developing therapeutics for the prevention and/or treatment of human disease (e.g., for small molecule drug development, target validation to early Phase II clinical trials).
– Therapeutic: Drugs (including small molecules, biologics, cell therapies and vaccines), medical devices or surgical interventions regulated by regulatory bodies such as the FDA. This definition includes therapeutics for all stages of disease including symptomatic relief, prevention, diagnosis and disease modification, but does not include complementary approaches such as exercise or acupuncture.
The basis for funding will be impact on neurodegenerative diseases of aging; however, research may be in any disease. Of diseases that affect more than 1,000 Canadians, the Foundation considers the following to be neurodegenerative diseases of aging:
– Alzheimer’s disease
– Parkinson’s disease
– Dementia with Lewy Bodies
– Frontotemporal dementia
– Amyotrophic lateral sclerosis
– Multiple system atrophy
– Mild cognitive impairment as prodromal to one of the above diseases
The Foundation will commit up to $4 million to this funding program. Grants can be up to $500,000 per project each year over three years to a maximum of $1.5 million per project.
Deadline: March 28, 2013
The Faculty of Medicine is launching an internal Canada Research Chairs (CRC) competition to fill three vacant CRC Tier 2 Chairs who will go forward to the national CRC competition in October 2013.
These Chairs will be available for: a) Tier 2 Retention, b) Tier 2 New Recruitment, or c) Tier 2 to Tier 1 advancement.
Please find the full details for the competition at the website above.
Deadline: April 2, 2013, 4:00pm PST
The 4 What Matters Foundation UBC Diabetes Fellowship is made possible by a generous donation from the 4 What Matters Foundation. This research training award is intended to provide one-year of salary support for an exceptional post-doctoral fellow to train in diabetes research in a UBC-based laboratory.
For more information on eligibility and how to apply, please visit the website above.
Deadline: April 30, 2013
SRCFC Major Grants support biomedical research into intellectual impairment focused on the following:
- The causes and eventual cure of intellectual impairment, such as Autism and Down Syndrome, especially as it affects children.
- The causes and eventual cure of Alzheimer’s Disease.
- Research into other forms of intellectual impairment may be considered
Note: The focus of the research should be on the causes and cure of the disease as opposed to the active treatment or palliative care.
Applications are limited to researchers who have no more than five (5) years experience as an independent investigator as of January 1, 2013
The value of the grants is a maximum of $35,000 per year for a period of up to 3 years.
AWARDS AND HONOURS:
Deadline: March 18, 2013
The Keio Medical Science Prize gives recognition to the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine. It aims to promote worldwide advances in medicine and life sciences, to encourage the expansion of researcher networks throughout the world, and to contribute to the well-being of humankind.
Laureates receive a certificate of merit, medal, and a monetary award. The award ceremony and commemorative lectures are held at Keio University.
Please see the website for more information and to download the nomination form.
Deadline: March 29, 2013
This prize is given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research — as well as its uptake — to improve health and the health system in BC and globally. The prize winner will present at an MSFHR event to be scheduled later in 2013. The prize is valued at $10,000.
The Aubrey J. Tingle Prize was created to honour the important role that Dr. Tingle played as founding president & CEO of the Michael Smith Foundation for Health Research from 2001 to his retirement in June 2008. A pediatrician and immunologist, Dr. Tingle has maintained a lifelong interest in the role of viruses in disease, with particular interest in rubella arthritis and juvenile diabetes.
For more information or to nominate a candidate, please see further details the website above.
The Centre for Blood Research Seminar Series
Date: February 13th, 2013 12:00pm – 1:00pm
Location: LSC 3 – Life Sciences Centre, 2350 Health Sciences Mall
“Leukocyte telomere length as a marker of aging in HIV infection” by Dr. Hélène Côté, Associate Professor, Pathology & Laboratory Medicine, Associate Member, Women’s Health Research Institute.
Please see the attached Poster for more information.
Date: February 19, 2013
SPARC is pleased to announce it is organizing a workshop on Tuesday, Feb. 19th for researchers who are interested in learning more about the NSERC Collaborative Research and Development (CRD) Grant program. Participants will be able to discuss firsthand the details of this funding competition with Lynda Wood (Manager, Research Partnership Programs), who is from NSERC-Ottawa and an expert on the CRD program.
In addition to Ms. Wood attending this workshop, there will also be other NSERC representatives available to outline and discuss the CRD program. Ample time will be made available to have your questions answered, and to meet with Ms. Wood, other NSERC representatives and some successful UBC CRD applicants.
Note that the SPARC Office provides additional support services for researchers interested in CRDs, including one-on-one feedback and organizing expert Internal Reviews of CRD applications.
Dr. Rabab Ward, NSERC Coordinator, VPRIO, and David Woods, Research Partnership Officer from SPARC, will be present to welcome you and lead the discussion.
You can register for this workshop at the following webpage: http://research.ubc.ca/civicrm/event/info?reset=1&id=74
PLEASE NOTE: Registration is REQUIRED.
ALSO: The main workshop program will be held on Tuesday, February 19th from 1:00-3:00pm; Lunch will be made available from 12:00 noon to 1:00pm.
If you have any questions, please feel free to forward them to: email@example.com
Date: February 27, 2013
Want to get the competitive edge on submitting a proposal to the CHRP competition? Register for the Workshop at the link above.
On February 27, 2013 at 9am, Krissy Davidge, Senior Advisor, CIHR Ottawa will announce this year’s CHRP LOI and Full competition requirements.
Following, Dr. Urs Hafeli (Pharm Sci, UBC) will discuss how he put together his highly successful application and Dr. Todd Handy (Dept of Psychology, UBC), a CHRP review committee member will discuss the review process.
As this workshop is meant to be interactive please bring questions.
If you have any questions, please contact Burdena.Shea@ubc.ca from the SPARC office.